Search

Displaying results 4221 - 4230 of 10000 in total
  1. Drug

    Efloxate

    go.drugbank.com/drugs/DB13333
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  2. Drug

    Trolnitrate

    go.drugbank.com/drugs/DB13719
    Experimental

    Categories: Vasodilators Used in Cardiac Diseases
  3. Drug

    Malachite Green

    go.drugbank.com/drugs/DB03895
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    Indole-3-Glycerol Phosphate

    go.drugbank.com/drugs/DB04143
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Bromopyruvate

    go.drugbank.com/drugs/DB17135
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Riferminogene pecaplasmid

    go.drugbank.com/drugs/DB06394
    Investigational

    Riferminogene pecaplasmid (non-viral fibroblast growth factor 1; NV1FGF) is a recombinant DNA plasmid in a pCOR backbone allowing expression of human FGF1.

  7. Drug

    LY-517717

    go.drugbank.com/drugs/DB05713
    Investigational

    LY517717 is an investigational oral direct inhibitor of activated Factor Xa. It is believed to be Lilly's PMD-3112 (licensed from Amgen).

  8. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure

  9. Drug

    Tacrine

    go.drugbank.com/drugs/DB00382
    ApprovedWithdrawn

    A centerally active cholinesterase inhibitor that has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous

  10. Drug

    CEP-1347

    go.drugbank.com/drugs/DB05403
    Investigational

    CEP-1347 is a semi-synthetic compound shown to protect multiple nerve cell types from a variety of insults leading to programmed cell death (apoptosis) which could improve the survival of dopamine neurons